---
title: "TMCI.US (TMCI.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TMCI.US/news.md"
symbol: "TMCI.US"
name: "TMCI.US"
parent: "https://longbridge.com/en/quote/TMCI.US.md"
datetime: "2026-06-13T23:37:35.506Z"
locales:
  - [en](https://longbridge.com/en/quote/TMCI.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TMCI.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TMCI.US/news.md)
---

# TMCI.US (TMCI.US) — Related News

### [Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch](https://longbridge.com/en/news/289404778.md)
*2026-06-11T03:09:02.000Z*
> Top biotech gainers included Parabilis (PBLS), which surged 58% following its Nasdaq IPO debut, and Clover Health (CLOV)

### [CEO Makes Bold Insider Move at Treace Medical Concepts](https://longbridge.com/en/news/288359150.md)
*2026-06-02T02:12:28.000Z*
> Treace Medical Concepts CEO John T. Treace purchased 50,000 shares valued at $177,500 on June 1, 2026, signaling confide

### [Cardinal (CDNL) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/288301348.md)
*2026-06-01T15:50:36.000Z*
> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of

### [Major Insider Buy Signals Growing Confidence at Treace Medical Concepts](https://longbridge.com/en/news/288004252.md)
*2026-05-29T02:15:25.000Z*
> Insider buying at Treace Medical Concepts (TMCI) by CEO John T. Treace, who purchased 115,520 shares for $339,704, indic

### [Treace Medical Shareholders Back Directors, Pay and Auditor](https://longbridge.com/en/news/287131061.md)
*2026-05-20T23:42:58.000Z*
> At Treace Medical's annual meeting, shareholders elected directors for three-year terms, approved executive compensation

### [](https://longbridge.com/en/news/286131702.md)
*2026-05-12T16:05:01.000Z*
> Treace Medical Concepts shares are trading higher after the company reported better-than-expected Q1 financial results a
